Intriguingly, blocking the bioactivities of ActRIIB has been shown to reverse cancer-induced cachexia and cardiac atrophy, and this response resulted in the extended lifespan of the experimental animals even without reducing the tumor growth (Zhou et al., 2010). The gene discussed is ACVR2B; the disease is Cachexia.